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Background: Magnetic resonance imaging (MRI) is a standard of care in evaluating many disease
processes. Given concerns about device damage or movement, programming changes, lead heating, inap-
propriate pacing, and image artifact, MRI is contraindicated in pacemaker patients. Despite this, studies
have demonstrated safety and efficacy of MRI in adults with acquired heart disease and endocardial pac-
ing leads. We sought to evaluate MRI use in congenital heart disease (CHD) patients with predominantly
epicardial pacing leads.
Methods: From July 2007 to October 2008, MRI (1.5 Tesla) was performed in 11 patients without alter-
native imaging modality who were not pacemaker dependent or possessing abandoned leads. Pacing was
disabled during MRI. An electrophysiologist monitored electrocardiogram and hemodynamic parameters
throughout each study. Device and lead function were evaluated before and after MRI, and at subsequent
clinic visits.
Results: Eleven MRIs (four cardiac, seven noncardiac) were performed in eight patients. Mean patient
age was 16.5 ± 9.2 years (range 1.7–24.5) with five patients under the age of 16 years. Diagnoses included
structural CHD in six patients and long QT syndrome and congenital heart block in one each. There
were three dual- and five single- (three atrial, two ventricular) chamber devices, two endocardial, and
nine epicardial leads. No inappropriate pacing or significant change in generator or lead parameters was
noted. All MRI studies were of diagnostic quality.
Conclusion: Diagnostic quality MRI can be performed safely in nonpacemaker-dependent CHD patients
with predominantly epicardial leads. Further studies will define safe practice measures in this population,
as well as in CHD patients with pacemaker dependency. (PACE 2009; 32:450–456)
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Introduction
Magnetic resonance imaging (MRI) has
evolved into the diagnostic imaging modality of
choice for many musculoskeletal and central ner-
vous system disorders. Its use in the evaluation
of congenital and acquired cardiac disease is also
rapidly increasing. Until recently, the presence of
a pacemaker has been considered an absolute con-
traindication to undergoing MRI because of po-
tential adverse affects of strong magnetic fields
on pacemaker systems and possible patient injury.
Specific concerns include potential device move-
ment,1–4 programming changes, induced lead cur-
rents that could lead to tissue heating and/or in-
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appropriate cardiac stimulation,3–5 or inhibition
of pacing.3,4,6
As indications for both pacemaker placement
and MRI expand, it is estimated that 50–75% of
individuals with a pacemaker will need an MRI
over the lifetime of their device.7 Researchers have
begun to investigate the use of MRI in selected
adult patients with acquired heart disease and
pacemaker systems that utilize endocardial leads.
Single-center studies demonstrate that MRI can be
performed in such patients without complication
or compromise in image quality.8–10
The safety of MRI in young congenital heart
disease (CHD) patients is particularly relevant.
This group of complex patients in whom cardiac
MRI is most beneficial is also the group frequently
requiring pacemakers. Many require epicardial,
rather than endocardial, leads because of abnor-
mal venous routes to the heart, as well as the risk
of systemic embolus from residual intracardiac
shunting. No studies to date address this popu-
lation. Therefore, this study sought to evaluate the
safety and efficacy of MRI in both pediatric and
adult CHD patients with pacemakers.
C©2009, The Authors. Journal compilation C©2009 Wiley Periodicals, Inc.
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Table I.
Protocol for the Performance of MRI in Patients
with Implanted Pacemakers
(1) Scheduling to be coordinated with
electrophysiologist on call.
(2) Review of implanted and abandoned hardware. CXR
to be performed if history not available.
(3) Perform unpaced ECG or rhythm strip.
(4) Pacemaker-dependent patients:
(a) Confirm necessity of MRI without acceptable
imaging alternative.
(b) Reprogram to AOO/VOO mode and observe
clinical condition and tolerance.
(5) Interrogate, perform capture thresholds, sensing,
and impedance measurements.
(6) Programming OOO/OAO/OVO/ODO mode during
scan (or in pacemaker-dependent patients to AOO
or VOO mode).
(7) Electrophysiologist approval and attendance at
entire study.
(8) Resuscitation cart should be available.
(9) Informed consent obtained.
(10) All antitachycardia functions of device turned off.
(11) All scans to be performed on 1.5 Tesla magnet.
(12) Post-MRI pacemaker interrogation with thresholds,
sensing, and impedance measurements.
(13) Reprogramming to original settings, including
reinitiation of all antitachycardia functions.
Methods
Patient Selection
Based on published adult studies, a protocol
(Table I) was developed for pediatric and CHD
patients with pacemakers undergoing MRI. The
Pediatric Radiology and Pediatric Cardiology fac-
ulties, as well as the Institutional Review Board,
approved this protocol. Patients were included if
they had a pacemaker and required imaging that
could only be obtained through MRI, regardless
of their age or type of MRI to be performed. Rela-
tive contraindications included pacemaker depen-
dency, abandoned leads, and pacing systems older
than 10 years (Table II).
Magnetic Resonance Imaging
All imaging was performed using a GE Medi-
cal Systems (Milwaukee, WI, USA) 1.5 Tesla Signa
LX Echospeed system. Coils were chosen as in-
dicated for the body part being imaged based
on patient size. Cardiac studies were performed
utilizing breath-holding when possible, to limit
motion artifact. The following sequences were
employed across study types: (1) three plane lo-
Table II.
Relative Contraindications
(1) Fragments of old pacing systems and equipment.
(2) Abandoned lead or leads.
(3) Older generation pacing generators.
(4) High radiofrequency exposure expected immediately
around device.
(5) Inability to program pacing to off; pacemaker
dependency.
calizer, (2) electrocardiogram-triggered segmented
k-space fast-spoiled gradient-recalled cine se-
quences (SSFP), (3) T1 and T2 imaging in multiple
planes, (4) double-inversion recovery sequences
in multiple planes, and (5) echo planar imaging
specific for brain study. Specific absorption rate
(SAR) was not recorded, but rather monitored in
relation to safety parameters put forth by the Food
and Drug Administration (FDA).11 In the official
report, the physician reading the study noted the
effect, if any, of pacemaker system artifact on his
or her ability to interpret the MRI.
Device Interrogation and Programming
A pediatric electrophysiologist interrogated
each device immediately before and immediately
after the MRI, as well as at all subsequent clinic
visits. The technical and functional status of the
pacemaker system was evaluated using battery
voltage, pacing mode, lead capture thresholds,
sensing signal amplitudes, and lead impedance.
Pacemaker dependence was determined by a re-
view of medical records and unpaced electro-
cardiogram (ECG) or rhythm strip prior to MRI.
Pacemaker settings were then reprogrammed to
sensing-only mode (OAO, OVO, or ODO) and all
atrial antitachycardia functions of the device were
turned off during the procedure. Patients were
monitored for at least 15 minutes with the pace-
maker in the passive mode before entering the MRI
scanner. Following the MRI, all devices were rein-
terrogated and reprogrammed to their original set-
tings, including reinitiation of all antitachycardia
functions.
Patient Monitoring during MRI
Both the physician performing the MRI (pe-
diatric radiologist or cardiologist) and the elec-
trophysiologist were present throughout the en-
tire study. Heart rate and oxygen saturation were
monitored continuously with magnetic resonance-
compatible optically encoded ECG and pulse
oximetry. Audio contact between the patient and
physicians was maintained via an intercom system
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in unsedated patients of appropriate age. Patients
were asked to inform the physicians of any dis-
comfort during the procedure, such as pain, chest
tension or warmth, palpitations, or dizziness. Full
resuscitation equipment was present throughout
the procedure.
Data Analysis
Continuous demographic variables were sum-
marized as mean and standard deviation. Paired
T-tests were performed when appropriate using
Minitab (Minitab Inc., State College, PA, USA).




Between July 2007 and October 2008, no
pacemaker-dependent patient presented for MRI.
One patient with an abandoned defibrillator lead
was excluded. The remaining eight patients un-
derwent 11 MRI studies (Table III) and ranged
in age from 1.7 to 24.5 years (mean 16.5 ± 9.2
years) with five patients under the age of 16 years.
Structural CHD was present in six patients, long
QT syndrome in one patient, and congenital com-
plete heart block in one patient. There were three
dual- and five single- (three atrial, two ventricu-
lar) chamber systems. The dual-chamber ventric-
ular systems and one atrial system accounted for
the nine epicardial leads. The remaining atrial
systems accounted for the two endocardial leads.
Mean pacemaker generator, atrial lead, and ven-
tricular lead ages at time of MRI were 3.8 ±
2.9 years, 3.7 ± 2.9 years, and 8.1 ± 6.8 years,
respectively. Pacemakers included models from
both Medtronic (Minneapolis, MN, USA) and St.
Jude Medical (Sylmar, CA, USA) with leads from
Medtronic, Intermedics (Pittsburgh, PA, USA),
and Guidant (Indianapolis, IN, USA). The two
youngest patients and one adult patient with se-
vere mental retardation required conscious seda-
tion during the MRI.
Safety and Device Function
All studies were completed without compli-
cation. No symptoms attributable to device mo-
tion, lead tension, or heating were reported during
the MRI. SAR values did not exceed FDA rec-
ommendations during any of our studies. No in-
appropriate pacing or arrhythmias occurred. All
devices functioned normally following the study.
Other than the change in pacing mode insti-
tuted by the electrophysiologist prior to the MRI,
no changes in device programming or electri-
cal resets were observed. Device voltages, sens-
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Table IV.
Pacemaker System Characteristics Immediately before and after MRI
Battery A Sensing A Capture A Lead V Sensing V Capture V Lead
Voltage Threshold Threshold Impedance Threshold Threshold Impedance
Study (V) (mV) (V @ msec) (ohms) (mV) (V @ msec) (ohms)
1 2.77 2.77 5.6 5.6 0.8/0.4 0.8/0.4 518 518 11.2 11.2 1.5/0.5 1.5/0.5 674 674
2 2.74 2.74 N/A N/A N/A N/A N/A N/A 12.5 12.5 1.5/0.5 1.5/0.5 270 343
3 2.78 2.78 2.0 1.4 2.3/0.5 2.3/0.5 529 530 22.4 15.7 1.5/0.5 1.5/0.5 882 969
4 2.80 2.75 4.7 4.7 0.8/0.5 0.8/0.5 454 447 12.0 12.0 1.0/0.5 1.0/0.5 692 698
5 2.69 2.70 N/A N/A N/A N/A N/A N/A 10.0 9.0 1.8/0.5 1.8/0.5 274 269
6 2.73 2.73 2.8 2.8 0.5/0.4 0.5/0.4 614 632 N/A N/A N/A N/A N/A N/A
7 2.75 2.75 5.6 5.6 1.0/0.4 1.0/0.4 612 613 N/A N/A N/A N/A N/A N/A
8 2.75 2.74 5.6 5.6 1.0/0.4 1.0/0.4 620 604 N/A N/A N/A N/A N/A N/A
9 2.75 2.74 5.6 5.6 1.0/0.4 1.0/0.4 550 548 N/A N/A N/A N/A N/A N/A
10 3.02 3.02 1.4 1.3 0.5/0.5 1.0/0.5 680 672 N/A N/A N/A N/A N/A N/A
11 2.74 2.74 5.6 5.6 1.0/0.4 1.3/0.4 583 568 N/A N/A N/A N/A N/A N/A
P value 0.28 0.27 0.20 0.41 0.30 N/A 0.18
Abbreviations: V = volts; mV = millivolts; ms = milliseconds; A = atrial; V = ventricular; N/A = not applicable.
impedances were similar immediately before and
after MRI (Table IV, P = 0.18–0.41). There was no
detectable change in ventricular capture thresh-
olds tested immediately before and after MRI,
eliminating the need for statistical analysis of this
variable. Minimal changes (not felt to be clinically
important) in device voltage, lead thresholds, or
lead impedances were noted in the six patients
who have had clinic follow-up at a mean of 5.5 ±
5.0 months.
Image Quality
Artifact from a pacing device or associated
lead did not affect the diagnostic quality of the
images (Fig. 1). Mild artifact with steady-state free-
precession imaging was attributed to the atrial lead
located in the systemic baffle of one patient with
d-transposition of the great arteries palliated with
a Mustard procedure. However, double-inversion
recovery sequences provided artifact-free imaging
of the area of interest and the superior vena cava
was seen to enter the right atrium without obstruc-
tion (Fig. 2).
Discussion
This study evaluates the safety and efficacy
of MRI in pediatric and adult CHD patients
with pacemakers and predominantly epicardial
leads. Our results suggest that both noncardiac
and cardiac MRI can be performed safely and
with diagnostic quality in this population. These
results are similar to results from studies in
adults with acquired heart disease and endocar-
dial leads.8–10,12,13
Given concerns regarding safety of MRI in
patients with pacemakers, we adhered to key
safety elements from published adult protocols
including review of current and abandoned pac-
ing hardware, analysis of pacemaker dependency,
pacemaker inhibition during MRI, and careful
monitoring of clinical status during the examina-
tion.8–10 Review of pacing hardware was particu-
larly important as it not only identified abandoned
leads that might be subject to more unpredictable
currents and heating, but also allowed comparison
with systems evaluated in previously published
studies. Because reports demonstrating functional
issues in pacemakers exposed to prolonged MRI
scan are limited to older generation pacing sys-
tems, such systems were considered a relative
contraindication to MRI.4 As the use of MRI
has only been reported in a small number of
pacemaker-dependent patients, we also consid-
ered pacemaker dependency a relative contraindi-
cation to MRI.9,13 However, no such patients
presented during the study period. Reprogram-
ming to an asynchronous mode and inhibition of
atrial antitachycardia mechanisms protected pa-
tients from inappropriate pacemaker actions re-
lated to detection of radiofrequency pulses. No
deaths have been reported during MRI studies
supervised by physicians.8 Utilizing this proto-
col, no adverse events were noted in our study
group.
Some authors have proposed avoiding MRI
in patients with epicardial pacing leads, theoriz-
ing that such leads may be more prone to heat-
ing given the lack of exposure to blood flow
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Figure 1. (A) Radiograph of the chest in a 1-year-old fe-
male with double-outlet right ventricle s/p repair com-
plicated by complete heart block necessitating place-
ment of a dual-chamber epicardial pacing system. (B)
Double-inversion recovery MRI in the same patient
demonstrating a coronal image through the SVC/RA
junction and left ventricle without the presence of ar-
tifact from the pacing system.
and associated cooling mechanisms.9 However,
in vitro data would suggest that the heating of leads
not surrounded by blood flow is negligible when
using standard MRI protocols.14 Our findings sup-
port these data as no clinically significant changes
were noted in the parameters of the nine epicardial
Figure 2. Double-inversion recovery MRI in the coro-
nal plane demonstrating patency of the superior vena
cava-right atrial junction in a 24-year-old male with
DTGA s/p Mustard procedure with sinus node dysfunc-
tion and a single-chamber (atrial) endocardial pacing
system. The generator can be seen located in left infra-
clavicular region.
leads following MRI. Similarly, no patients com-
plained of symptoms attributable to lead heating.
Other authors have suggested that the proximity
of the pacemaker system to the area being im-
aged may affect MRI safety.15,16 Our study does
not support this as one-half of our population un-
derwent MRI of the thoracic region and showed no
clinically significant change in any device or lead
parameters.
The quality of the MRI image may be altered
by the presence of ferromagnetic materials in the
area of interest leading to variations of the sur-
rounding magnetic field and image distortion. This
is of particular concern in patients undergoing car-
diac MRI, given the proximity of the generator
and leads to the area being imaged. Studies per-
formed in adult populations with acquired heart
disease and endocardial leads have demonstrated
high image quality and diagnostic yield from car-
diac MRI studies.9 Similarly, in our study popula-
tion (including five children), minor artifact was
noted in only one scan, related to a pacemaker
lead in the area of interest. It did not, however,
prevent demonstration of the vessel and provided
adequate information regarding patency.
Patients with complex structural heart dis-
ease have a high likelihood of eventually requiring
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a pacing system for sinus node dysfunction,
heart block, or tachycardia management. In
addition, this population frequently has poor
echocardiographic windows and will require se-
rial cardiac MRI for both structural assessment
and quantification of flow and ventricular func-
tion. Serial computed tomography (CT) is a poor
alternative as it involves significant radiation
exposure.17 Furthermore, potential adverse af-
fects of CT on pacemaker function are begin-
ning to be reported.18,19 These concerns about
CT use as an alternative to MRI are particu-
larly concerning in the pediatric population with
pacemakers as the risk of radiation damage is
greater in the child with cumulative increases over
time.17
Patients with CHD requiring pacemakers and
both cardiac and noncardiac MRI represent a grow-
ing clinical problem. It is now expected that 90%
of patients born with CHD will survive to adult-
hood and accordingly, this population increases
approximately 5% per year. Our study provides
early data that the current restriction of MRI in
these patients may not be warranted. Furthermore,
current protocols, such as ours, call for placing
pacemakers in sensing-only mode during MRI.
Such precautions can alter the ventricular activa-
tion sequence and adversely affect CHD patients
who require atrioventricular synchrony for ade-
quate cardiac output during the exam. As pac-
ing systems evolve, further investigations of MRI
in both nondevice-dependent and dependent pa-
tients are needed to provide guidelines regarding
the safe use of MRI in the CHD patient with epi-
cardial leads.
Study Limitations
There are several limitations to this study.
First, given the strict entry criteria and high the-
oretical risks of MRI in pacemaker patients, the
sample size is small and limits our ability to iden-
tify all potential complications. Second, follow-up
in this study was limited to a mean of 5.5 months
and, accordingly, long-term complications could
not be detected. Third, none of the patients in
this study were pacemaker dependent, so we have
no information regarding MRI use in this group.
Last, in keeping with our facility’s standard op-
erating procedure, exact SAR was not recorded.
The present findings are limited to 1.5 Tesla scan-
ners and should not be extrapolated to scanners
with higher field strengths that typically generate
a higher SAR, as this could increase the risk for
inappropriate heating of the pacemaker device or
associated leads.
Conclusion
This pilot study suggests that given appro-
priate precautions, diagnostic quality MRI can be
safely performed in nonpacemaker-dependent pe-
diatric and adult CHD patients, even those with
epicardial leads. Larger studies are required to bet-
ter define safe practice measures. Further studies
are also needed to determine the safety and effi-
cacy of MRI in pediatric and adult CHD patients
who are pacemaker dependent.
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